In a landmark continuing collaboration, Answer ALS and Cedars-Sinai have announced the completed availability of the largest amyotrophic lateral sclerosis (ALS) patient-based induced pluripotent stem ...
The National Institute of Aging awarded a $7.3 million research grant for the study of NU-9 as a treatment for ...
The newly combined company will focus on moving Kadimastem's AstroRx, NLS's DOXA platform, and other therapies through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback